1. ACTR-45. PHASE 0/2 STUDY OF RIBOCICLIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (5th November 2018) Authors: Tien, An-Chi; Bao, Xun; Derogatis, Alanna; Kim, Seongho; Mehta, Shwetal; Li, Jing; Sanai, Nader Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-13. A FIRST-IN-HUMAN PHASE 0/1 TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY (5-ALA SDT) IN RECURRENT GLIOBLASTOMA. (14th November 2022) Authors: Sanai, Nader; Tien, An-Chi; Tovmasyan, Artak; Chang, Yu-Wei; Margaryan, Tigran; Hendrickson, Kristen; Eschbacher, Jennifer; Yoo, Wonsuk; Harmon, Jocelyn; Hong, Amy; Quarles, Christopher; Barani, Igor; Alhilali, Lea; Mirzadeh, Zaman; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-14. A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS. (14th November 2022) Authors: Sanai, Nader; Margaryan, Tigran; Molloy, Jennifer; Knight, William; Harmon, Jocelyn; Hong, Amy; Wanebo, John; Kennedy, William; Garcia, Michael; Barani, Igor; Yoo, Wonsuk; Tien, An-Chi; Tovmasyan, Artak; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-20. FEASIBILITY OF SINGLE-PASS STEREOTACTIC NEEDLE BIOPSY IN RECURRENT GLIOBLASTOMA PATIENTS TO SUPPORT CLIA-CERTIFIED TUMOR PHARMACODYNAMICS FOR A PHASE 0/2 CLINICAL TRIAL. (12th November 2021) Authors: Chang, Yu-Wei; DeSantis, Anita; Pennington-Krygier, Chelsea; Molloy, Jennifer; Mehta, Shwetal; Sanai, Nader; Tien, An-Chi Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-22. A PHASE 0/1 'TRIGGER' TRIAL OF RIBOCICLIB PLUS EVEROLIMUS IN RECURRENT HIGH-GRADE GLIOMA. (12th November 2021) Authors: Sanai, Nader; Tien, An-Chi; Jiang, Jun; Chang, Yu-Wei; Pennington-Krygier, Chelsea; DeSantis, Anita; Fujita, Yoko; Kim, Seongho; Li, Jing; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTNI-23. A FIRST-IN-HUMAN PHASE 0/1 CLINICAL TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Sanai, Nader; Tien, An-Chi; Tovmasyan, Artak; Chang, Yu-Wei; Margaryan, Tigran; Hendrickson, Kristin; Eschbacher, Jennifer; Yoo, Wonsuk; Harmon, Jocelyn; Quarles, Christopher; Alhilali, Lea; Barani, Igor; Mehta, Shwetal; Mirzadeh, Zaman Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTNI-44. A PHASE 0 'TRIGGER' TRIAL OF PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA PATIENTS. (14th November 2022) Authors: Sanai, Nader; Chang, Yu-Wei; Jiang, Jun; Molloy, Jennifer; Montgomery, Chelsea; Harmon, Jocelyn; Hong, Amy; Wanebo, John; Kennedy, William; Garcia, Michael; Barani, Igor; Yoo, Wonsuk; Tovmasyan, Artak; Tien, An-Chi; Li, Jing; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-48. A PHASE 0 'TRIGGER' TRIAL OF CDK4/6 PLUS ERK1/2 INHIBITORS IN RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Sanai, Nader; Chang, Yu-Wei; Margaryan, Tigran; DeSantis, Anita; Elliott, Mackenna; Pennington-Krygier, Chelsea; Hook, Garry; Yoo, Wonsuk; Tien, An-Chi; Tovmasyan, Artak; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTNI-54. A PHASE 0/1 'TRIGGER' TRIAL OF RIBOCICLIB PLUS EVEROLIMUS IN RECURRENT HIGH-GRADE GLIOMA. (14th November 2022) Authors: Sanai, Nader; Tien, An-Chi; Jiang, Jun; Chang, Yu-Wei; Montgomery, Chelsea; DeSantis, Anita; Fujita, Yoko; Kim, Seongho; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EXTH-09. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE AURORA KINASE A INHIBITOR LY3295668. (12th November 2021) Authors: Mehta, Shwetal; Tovmasyan, Artak; Tien, An-Chi; Holter, Michael; Hopkins, Barbara; Margaryan, Tigran; Chang, Yu-Wei; Himes, Sarah; Elliott, Mackenna; Melendez, Ernesto Luna; Pennington-Krygier, Chelsea; White, Connor; Molloy, Jennifer; Liu, Miao; Knight, William; Sanai, Nader Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗